Iradimed Co Stock Market Value
| IRMD Stock | USD 53.58 0.83 1.57% |
| Symbol | Iradimed |
Iradimed Price To Book Ratio
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Iradimed. If investors know Iradimed will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Iradimed listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0) | Dividend Share 0.45 | Earnings Share 1.46 | Revenue Per Share 5.635 | Quarterly Revenue Growth 0.11 |
The market value of Iradimed is measured differently than its book value, which is the value of Iradimed that is recorded on the company's balance sheet. Investors also form their own opinion of Iradimed's value that differs from its market value or its book value, called intrinsic value, which is Iradimed's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Iradimed's market value can be influenced by many factors that don't directly affect Iradimed's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Iradimed's value and its price as these two are different measures arrived at by different means. Investors typically determine if Iradimed is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Iradimed's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Iradimed 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Iradimed's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Iradimed.
| 10/29/2024 |
| 11/28/2024 |
If you would invest 0.00 in Iradimed on October 29, 2024 and sell it all today you would earn a total of 0.00 from holding Iradimed Co or generate 0.0% return on investment in Iradimed over 30 days. Iradimed is related to or competes with Edwards Lifesciences, Outset Medical, Venus Concept, DexCom, Electrocore LLC, Vivos Therapeutics, and Electromed. IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging compatible medical devi... More
Iradimed Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Iradimed's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Iradimed Co upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.95 | |||
| Information Ratio | 0.0344 | |||
| Maximum Drawdown | 11.03 | |||
| Value At Risk | (2.53) | |||
| Potential Upside | 3.26 |
Iradimed Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Iradimed's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Iradimed's standard deviation. In reality, there are many statistical measures that can use Iradimed historical prices to predict the future Iradimed's volatility.| Risk Adjusted Performance | 0.079 | |||
| Jensen Alpha | (0.0004) | |||
| Total Risk Alpha | (0.14) | |||
| Sortino Ratio | 0.038 | |||
| Treynor Ratio | 0.1202 |
Iradimed Backtested Returns
Iradimed appears to be very steady, given 3 months investment horizon. Iradimed holds Efficiency (Sharpe) Ratio of 0.11, which attests that the entity had a 0.11% return per unit of risk over the last 3 months. We have found thirty technical indicators for Iradimed, which you can use to evaluate the volatility of the firm. Please utilize Iradimed's Market Risk Adjusted Performance of 0.1302, risk adjusted performance of 0.079, and Downside Deviation of 1.95 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Iradimed holds a performance score of 8. The company retains a Market Volatility (i.e., Beta) of 1.62, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Iradimed will likely underperform. Please check Iradimed's potential upside, rate of daily change, and the relationship between the sortino ratio and skewness , to make a quick decision on whether Iradimed's current trending patterns will revert.
Auto-correlation | 0.55 |
Modest predictability
Iradimed Co has modest predictability. Overlapping area represents the amount of predictability between Iradimed time series from 29th of October 2024 to 13th of November 2024 and 13th of November 2024 to 28th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Iradimed price movement. The serial correlation of 0.55 indicates that about 55.0% of current Iradimed price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.55 | |
| Spearman Rank Test | -0.11 | |
| Residual Average | 0.0 | |
| Price Variance | 1.4 |
Iradimed lagged returns against current returns
Autocorrelation, which is Iradimed stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Iradimed's stock expected returns. We can calculate the autocorrelation of Iradimed returns to help us make a trade decision. For example, suppose you find that Iradimed has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Iradimed regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Iradimed stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Iradimed stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Iradimed stock over time.
Current vs Lagged Prices |
| Timeline |
Iradimed Lagged Returns
When evaluating Iradimed's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Iradimed stock have on its future price. Iradimed autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Iradimed autocorrelation shows the relationship between Iradimed stock current value and its past values and can show if there is a momentum factor associated with investing in Iradimed Co.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Iradimed is a strong investment it is important to analyze Iradimed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Iradimed's future performance. For an informed investment choice regarding Iradimed Stock, refer to the following important reports:Check out Iradimed Correlation, Iradimed Volatility and Iradimed Alpha and Beta module to complement your research on Iradimed. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.
Iradimed technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.